Switch to:
More From Other Websites
Should You Buy OneBeacon Insurance Group, Ltd. (OB)? Nov 28 2015
[$$] Follow Up: Rival's Woes Bode Well for Sarepta Nov 28 2015
Why this company's $700 million bet could come up short Nov 25 2015
FDA Panel Seen As Bad For BioMarin, Good For Sarepta Nov 25 2015
Doubts about BioMarin drug Nov 25 2015
Here’s what former Sarepta CEO Chris Garabedian had to say about BioMarin’s drug panel Nov 25 2015
BioMarin: So You're Saying There's a Chance? Nov 25 2015
Is Air Methods Corp (AIRM) A Good Stock To Buy? Nov 25 2015
BioMarin's Duchenne Drug Is Done, Sarepta Survives but Faces Challenge Nov 25 2015
Sarepta Rises 5.3%, Helping XBI’s Small-Cap Stocks Nov 24 2015
BioMarin Drug's Future In Doubt After FDA Panel Vote Nov 24 2015
FDA panel: BioMarin muscle wastage drug data not persuasive Nov 24 2015
BioMarin Gets Unfavorable View From Panel on Duchenne Drug Nov 24 2015
​Here’s the latest on today’s FDA review of BioMarin’s Duchenne drug Nov 24 2015
Sarepta Therapeutics, Inc. – Value Analysis (NASDAQ:SRPT) : November 24, 2015 Nov 24 2015
​The first drug for Duchenne will be reviewed at the FDA today: Why it matters Nov 24 2015
IBB Leads Biotech ETFs with Rise of 3.1% Nov 23 2015
BioMarin Down on FDA's Briefing Document on Kyndrisa Nov 23 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership